<?xml version="1.0" encoding="UTF-8"?>
<ref id="b34-ijmm-43-01-0393" class="ref">
 <label class="label">34</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Shih</surname>
    <given-names class="given-names">MF</given-names>
   </name>
   <name class="name">
    <surname class="surname">Chen</surname>
    <given-names class="given-names">LY</given-names>
   </name>
   <name class="name">
    <surname class="surname">Tsai</surname>
    <given-names class="given-names">PJ</given-names>
   </name>
   <name class="name">
    <surname class="surname">Cherng</surname>
    <given-names class="given-names">JY</given-names>
   </name>
  </person-group>
  <article-title class="article-title">In vitro and in vivo therapeutics of Î²-thujaplicin on LPS-induced inflammation in macrophages and septic shock in mice</article-title>
  <source class="source">Int J Immunopathol Pharmacol</source>
  <volume class="volume">25</volume>
  <fpage class="fpage">39</fpage>
  <lpage class="lpage">48</lpage>
  <year class="year">2012</year>
  <pub-id pub-id-type="doi" class="pub-id">10.1177/039463201202500106</pub-id>
  <?supplied-pmid 22507316?>
  <pub-id pub-id-type="pmid" class="pub-id">22507316</pub-id>
 </element-citation>
</ref>
